 Biosecurity Act 2015

In New Zealand, khat is listed as a Class C drug, in the same category as cannabis and codeine.In South America, there is no legislation regarding khat; the active ingredients in the plant can be found in several weight control compounds sold in the continent.In 2009, the University of Minnesota launched the Khat Research Program (KRP), a multidisciplinary research and training program focusing on the neurobehavioral and health effects of khat, led by Prof. Dr. Mustafa al'Absi.